Original paper
Myasthenia gravis associated with anti‐MuSK antibodies developed after SARS‐CoV‐2 infection
Abstract
Since the onset of the novel coronavirus pandemic, several neurological complications secondary to SARS-CoV-2 infection have been reported, affecting central nervous system, peripheral nervous system and neuromuscular junction.We present the case of a 77-year-old man who developed bulbar myasthenia gravis (MG) eight weeks after SARS-CoV-2 infection. The search for serum antibodies against the acetylcholine receptor and the muscle-specific...
Paper Details
Title
Myasthenia gravis associated with anti‐MuSK antibodies developed after SARS‐CoV‐2 infection
Published Date
Jan 15, 2021
Volume
28
Issue
10
Pages
3537 - 3539